Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin

被引:0
|
作者
Ei Tae Kim
Lee Hoo Kim
Jung Il Lee
Hee Seung Chin
机构
[1] Inha University School of Medicine,Department of Ophthalmology
[2] Inha University School of Medicine,Division of Gastroenterology, Department of Internal Medicine
[3] Inha University Hospital,Department of Ophthalmology
来源
关键词
chronic hepatitis C; interferon; interferon-associated retinopathy; pegylated interferon;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:598 / 602
页数:4
相关论文
共 50 条
  • [41] Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C
    Zandieh, Iman
    Adenwalla, Mohamed
    Cheong-Lee, Cindy
    Ma, Patrick E.
    Yoshida, Eric M.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (30) : 4908 - 4910
  • [42] Combination therapy with pegylated interferon plus ribavirin in the treatment of hepatitis C virus-related thrombocytopenia
    Karakan, T
    Cindoruk, M
    Degertekin, B
    Dogan, I
    Sancak, A
    Dumlu, S
    Gorgul, A
    Unal, S
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (03): : 247 - 253
  • [43] Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
    Gamal, Nesrine
    Brodosi, Lucia
    Misciali, Cosimo
    Patrizi, Annalisa
    Vukatana, Gentiana
    Malavolta, Nazzarena
    Bernardi, Mauro
    Andreone, Pietro
    [J]. ANNALS OF HEPATOLOGY, 2014, 13 (02) : 293 - 296
  • [44] EFFECT OF FLUVASTATIN-COMBINED PEGYLATED-INTERFERON/RIBAVIRIN COMBINATION THERAPY ON CHRONIC HEPATITIS C
    Kondo, Chisa
    Atsukawa, Masanori
    Itokawa, Norio
    Hashimoto, Satomi
    Fukuda, Takeshi
    Matsushita, Yoko
    Kidokoro, Hideko
    Katakura, Tamaki
    Narahara, Yoshiyuki
    Nakatsuka, Katsuhisa
    Kanazawa, Hidenori
    Tsubota, Akihito
    Sakamoto, Choitsu
    [J]. HEPATOLOGY, 2011, 54 : 989A - 989A
  • [45] Effect of combination therapy of interferon alpha and ribavirin in the patients with chronic hepatitis C
    Kim, Seok Hyn
    Lee, Byung Seok
    Lee, Heon Young
    Lee, Tae Hee
    Kang, Young Woo
    Park, Jeong Hoon
    Kim, Hong Su
    Kim, Suk Bae
    Song, Il Han
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A467 - A467
  • [46] Interferon and ribavirin associated retinopathy in patients with hepatitis C.
    Deeb, LS
    Khouri, AS
    Hall, CE
    Tamburro, CH
    [J]. HEPATOLOGY, 1998, 28 (04) : 371A - 371A
  • [47] Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Joonho Yoon
    Jong In Lee
    Soon Koo Baik
    Kwang Ho Lee
    Joon Hyung Sohn
    Hyean-Woo Lee
    Jun Namkung
    Sei Jin Chang
    Jong-Whan Choi
    Hyun-Won Kim
    Byung-Il Yeh
    [J]. World Journal of Gastroenterology, 2007, (46) : 6236 - 6242
  • [48] INTERFERON AND RIBAVIRIN COMBINATION THERAPY IN PATIENTS WITH HEPATITIS C RELATED HEPATOCELLULAR CARCINOMA
    Shin, Su Rin
    Paik, Seung Woon
    Jung, Han Young
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joan Hyoek
    Koh, Kwang Cheol
    Yoo, Byung Chul
    [J]. HEPATOLOGY, 2008, 48 (04) : 899A - 899A
  • [49] Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Nagaoki, Yuko
    Imamura, Michio
    Kawakami, Yoshiiku
    Kan, Hiromi
    Fujino, Hatsue
    Fukuhara, Takayuki
    Kobayashi, Tomoki
    Ono, Atsushi
    Nakahara, Takashi
    Naeshiro, Noriaki
    Urabe, Ayako
    Yokoyama, Satoe
    Miyaki, Daisuke
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Aikata, Hiroshi
    Takahashi, Shoichi
    Hayes, C. Nelson
    Ochi, Hidenori
    Chayama, Kazuaki
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (14) : E447 - E454
  • [50] Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C
    Horiike, N
    Onji, M
    [J]. JOURNAL OF GASTROENTEROLOGY, 2003, 38 (03) : 302 - 304